IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 56.993
AS - Asia 5.125
EU - Europa 4.712
SA - Sud America 779
AF - Africa 93
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 10
Totale 67.773
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 56.836
SG - Singapore 2.581
CN - Cina 1.142
DE - Germania 806
UA - Ucraina 697
BR - Brasile 687
IT - Italia 655
IE - Irlanda 586
HK - Hong Kong 557
FR - Francia 423
RU - Federazione Russa 384
GB - Regno Unito 319
FI - Finlandia 280
SE - Svezia 251
VN - Vietnam 210
KR - Corea 163
CA - Canada 87
IN - India 84
JP - Giappone 76
PL - Polonia 71
BE - Belgio 65
MX - Messico 54
ID - Indonesia 44
NZ - Nuova Zelanda 43
NL - Olanda 42
ZA - Sudafrica 38
TW - Taiwan 35
BD - Bangladesh 34
AR - Argentina 31
IR - Iran 30
UZ - Uzbekistan 30
ES - Italia 28
IQ - Iraq 22
PK - Pakistan 21
TR - Turchia 21
AT - Austria 20
AU - Australia 17
EC - Ecuador 17
LT - Lituania 14
MA - Marocco 13
MY - Malesia 13
AE - Emirati Arabi Uniti 12
LV - Lettonia 11
CZ - Repubblica Ceca 10
RO - Romania 10
CO - Colombia 8
KE - Kenya 8
VE - Venezuela 8
CL - Cile 7
EG - Egitto 7
IL - Israele 7
TN - Tunisia 7
UY - Uruguay 7
ET - Etiopia 6
GR - Grecia 6
JO - Giordania 6
KG - Kirghizistan 6
BG - Bulgaria 5
DZ - Algeria 5
PE - Perù 5
PY - Paraguay 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EU - Europa 4
OM - Oman 4
PH - Filippine 4
SI - Slovenia 4
BO - Bolivia 3
CH - Svizzera 3
GH - Ghana 3
JM - Giamaica 3
LB - Libano 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
CI - Costa d'Avorio 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
Totale 67.765
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.549
Wilmington 15.051
Houston 13.910
Fairfield 1.633
Ann Arbor 1.431
Singapore 1.187
Chandler 1.084
Ashburn 971
Seattle 648
Jacksonville 592
Hong Kong 551
Cambridge 538
Dublin 510
Beijing 459
Medford 418
New York 331
Dallas 302
The Dalles 247
Santa Clara 229
Los Angeles 221
Lawrence 196
Dearborn 192
Rome 183
Helsinki 137
Zhengzhou 124
Moscow 87
Buffalo 81
São Paulo 80
Menlo Park 79
Chicago 75
San Diego 74
Mülheim 71
Boardman 70
Redwood City 70
Ho Chi Minh City 66
Council Bluffs 59
London 54
Munich 54
Brussels 52
Hanoi 52
Milan 52
Nanjing 47
Shanghai 44
Tauranga 42
Falls Church 41
Norwalk 40
Palo Alto 39
Seoul 38
Kraków 36
Toronto 36
Redondo Beach 35
Nuremberg 32
Mountain View 30
Phoenix 30
Hefei 29
Stockholm 29
Columbus 27
Denver 27
Kunming 27
Warsaw 27
Chengdu 26
Johannesburg 26
San Mateo 26
Tokyo 26
Verona 26
Jakarta 25
San Jose 25
Guangzhou 24
University Park 24
Brooklyn 22
Taipei 22
Montreal 21
Amsterdam 20
Boston 19
Frankfurt am Main 19
Chennai 18
Orem 18
San Francisco 18
Atlanta 17
Dong Ket 16
Augusta 15
Rio de Janeiro 15
Shenzhen 15
Porto Alegre 14
Baghdad 13
Belo Horizonte 13
Brasília 13
Curitiba 13
Jinan 13
Bassano del Grappa 12
Poplar 12
Scottsdale 12
Detroit 11
Esslingen am Neckar 11
Mexico City 11
Nürnberg 11
Ankara 10
Dhaka 10
Las Vegas 10
Paris 10
Totale 59.108
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 616
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 547
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 512
Gonadal mosaicism in hereditary angioedema 509
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 485
Complement and autoimmunity 481
NK cells in autoimmunity: A two-edg'd weapon of the immune system 477
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 474
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 474
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 472
Glutathione: A key player in autoimmunity 470
Vasculitides and the Complement System: a Comprehensive Review 470
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 470
Serum thymosin alpha 1 levels in normal and pathological conditions 470
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 466
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 465
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 462
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 462
Autoantibodies in inflammatory arthritis 461
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 459
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 458
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 456
Apremilast for the treatment of psoriasis. 456
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 456
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 455
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 454
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 451
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 450
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 447
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 444
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 443
High-dose intravenous immunoglobulin treatment activates complement in vivo 442
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 442
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 441
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 440
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 440
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 438
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 438
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 437
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 437
Evidence of impaired sense of smell in hereditary angioedema 436
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 432
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 431
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 430
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 428
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 427
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 426
The type I IFN system in rheumatoid arthritis 425
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 425
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 423
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 422
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 422
HELLP syndrome: A complication or a new autoimmune syndrome? 421
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 421
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 421
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 419
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 418
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 418
Antimyocardial Autoantibodies (AMCA) 417
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 416
Behcet's disease and etanercept: eighty weeks of experience 416
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 415
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 414
The European register of hereditary angioedema: Experience and preliminary results 414
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 414
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 412
Complement, infection, and autoimmunity 411
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 410
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 409
ADA genetic polymorphism and total plasma IgE level in healthy adults 408
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 407
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 407
Auto-reactions, autoimmunity and psoriatic arthritis 407
Cystic ovaries in women affected with hereditary angioedema. 406
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 405
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 404
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 403
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 403
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 402
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 400
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 400
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 400
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 400
Insights on the role of physical activity in patients with rheumatoid arthritis 400
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 400
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 397
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 394
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 394
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 393
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 393
Novelties in the field of autoimmunity – 1st Saint Petersburg congress of autoimmunity, the bridge between east and west 392
The interplay between inflammation and metabolism in rheumatoid arthritis 391
NK cells, autoantibodies, and immunologic infertility: a complex interplay 390
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 390
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 390
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 389
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 388
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 388
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 385
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 385
Totale 43.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.851
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.851
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.688 0 0 0 0 0 1.144 1.340 1.126 359 240 382 97
2021/20222.080 108 221 157 118 84 128 101 99 101 198 180 585
2022/20232.657 241 230 97 369 252 582 205 162 264 39 154 62
2023/20241.028 132 41 48 35 85 317 29 106 19 26 16 174
2024/20254.624 181 984 494 275 105 308 215 185 436 417 585 439
2025/20264.066 596 338 1.094 833 820 385 0 0 0 0 0 0
Totale 68.509